A detailed history of Torray LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Torray LLC holds 21,251 shares of ABBV stock, worth $3.48 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
21,251
Previous 21,190 0.29%
Holding current value
$3.48 Million
Previous $3.86 Million 0.29%
% of portfolio
0.61%
Previous 0.32%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $9,749 - $11,108
61 Added 0.29%
21,251 $3.87 Million
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $94,133 - $107,256
589 Added 2.86%
21,190 $3.86 Million
Q4 2023

Feb 08, 2024

SELL
$137.6 - $154.97 $81,046 - $91,277
-589 Reduced 2.78%
20,601 $3.19 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $326,761 - $378,273
2,446 Added 13.05%
21,190 $3.16 Million
Q2 2023

Jul 20, 2023

BUY
$132.51 - $164.9 $3,577 - $4,452
27 Added 0.14%
18,744 $2.53 Million
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $33,115 - $38,137
229 Added 1.24%
18,717 $2.98 Million
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $33,056 - $39,642
239 Added 1.31%
18,488 $2.99 Million
Q3 2022

Nov 04, 2022

BUY
$134.21 - $153.93 $163,333 - $187,332
1,217 Added 7.15%
18,249 $2.45 Million
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $2.34 Million - $2.98 Million
17,032 New
17,032 $2.61 Million
Q1 2022

May 03, 2022

SELL
$131.98 - $163.75 $2.71 Million - $3.36 Million
-20,529 Closed
0 $0
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $83,365 - $105,481
776 Added 3.93%
20,529 $2.78 Million
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $24,259 - $27,537
228 Added 1.17%
19,753 $2.13 Million
Q2 2021

Aug 03, 2021

SELL
$105.21 - $117.21 $6,838 - $7,618
-65 Reduced 0.33%
19,525 $2.2 Million
Q1 2021

May 03, 2021

SELL
$102.3 - $112.62 $2,148 - $2,365
-21 Reduced 0.11%
19,590 $2.12 Million
Q4 2020

Feb 03, 2021

SELL
$80.49 - $108.67 $79,363 - $107,148
-986 Reduced 4.79%
19,611 $2.1 Million
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $9,278 - $10,889
108 Added 0.53%
20,597 $1.8 Million
Q2 2020

Aug 03, 2020

SELL
$73.37 - $98.18 $202,868 - $271,467
-2,765 Reduced 11.89%
20,489 $2.01 Million
Q1 2020

Apr 28, 2020

SELL
$64.5 - $97.79 $393,127 - $596,030
-6,095 Reduced 20.77%
23,254 $1.77 Million
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $33,396 - $41,785
-463 Reduced 1.55%
29,349 $2.6 Million
Q3 2019

Nov 06, 2019

BUY
$62.98 - $75.72 $17,382 - $20,898
276 Added 0.93%
29,812 $2.26 Million
Q2 2019

Aug 08, 2019

BUY
$65.7 - $83.98 $169,703 - $216,920
2,583 Added 9.58%
29,536 $2.15 Million
Q1 2019

May 07, 2019

BUY
$77.14 - $90.79 $208,817 - $245,768
2,707 Added 11.16%
26,953 $2.17 Million
Q4 2018

Feb 06, 2019

BUY
$77.85 - $96.01 $294,817 - $363,589
3,787 Added 18.51%
24,246 $2.24 Million
Q3 2018

Nov 02, 2018

BUY
$88.91 - $98.84 $235,166 - $261,431
2,645 Added 14.85%
20,459 $1.94 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $231,991 - $274,498
2,584 Added 16.97%
17,814 $1.65 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $79,956 - $107,069
-869 Reduced 5.4%
15,230 $1.44 Million
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $153,505 - $168,331
1,714 Added 11.92%
16,099 $1.56 Million
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $1 Million - $1.28 Million
14,385
14,385 $1.28 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $290B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Torray LLC Portfolio

Follow Torray LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Torray LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torray LLC with notifications on news.